Athos develops AI-based Precision Therapeutics for patients with Inflammatory Bowel, other Autoimmune Diseases, and cancer.
Athos Therapeutics has raised $35.0M in total funding. The most recent round was Series B. The last funding was announced in February 2024.
Athos Therapeutics is headquartered in Torrance, United States.
Athos develops AI-based Precision Therapeutics for patients with Inflammatory Bowel, other Autoimmune Diseases, and cancer.
Athos Therapeutics is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Athos Therapeutics — Funding & Investors." VCBacked, February 16, 2024, https://www.vcbacked.co/company/athos-therapeutics. Accessed July 31, 2026.
VCBacked. (2024). Athos Therapeutics — Funding & Investors. Retrieved July 31, 2026, from https://www.vcbacked.co/company/athos-therapeutics
{{cite web |title=Athos Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/athos-therapeutics |website=VCBacked |access-date=July 31, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated